Original Research
Accepted on 27 Aug 2024
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer -Detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood
in Head and Neck Cancer